Osmotic Release Oral System-Methylphenidate Hydrochloride (OROS-MPH) versus atomoxetine on executive function improvement and clinical effectiveness in ADHD: A randomized controlled trial

References

• Adler, L., Tanaka, Y., Williams, D., Trzepacz, P. T., Goto, T., Allen, A. J., & Upadhyaya, H. P. (2014). Executive function in adults with attention-deficit/hyperactivity disorder during treatment with atomoxetine in a randomized, placebo-controlled, withdrawal study. Journal of Clinical Psychopharmacology, 34(4), 461–466.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association.
   Google Scholar
• Bakar, E. E. (2007). Dikkat Eksikliği Hiperaktivite Bozukluğunun Alt Tiplerine Ait Bilişsel Örüntüler. Doktora Tezi.
   Google Scholar
• Bakar, E. E., Taner, Y. I., Soysal, A. S., Karakas, S., & Turgay, A. (2011). Behavioral rating inventory and laboratory tests measure different aspects of executive functioning in boys: A validity study. Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology], 21(4), 302–316. https://doi.org/10.5455/bcp.20111004014003
   Web of Science ®Google Scholar
• Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 121(1), 65–94. https://doi.org/10.1037/0033-2909.121.1.65
   PubMed Web of Science ®Google Scholar
• Barkley, R. A., & Fischer, M. (2011). Predicting impairment in major life activities and occupational functioning in hyperactive children as adults: Self-reported executive function (EF) deficits versus EF tests. Developmental Neuropsychology, 36(2), 137–161. https://doi.org/10.1080/87565641.2010.549877
   PubMed Web of Science ®Google Scholar
• Bédard, A. C. V., Stein, M. A., Halperin, J. M., Krone, B., Rajwan, E., & Newcorn, J. H. (2015). Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention‐deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry, 56(1), 40–48. https://doi.org/10.1111/jcpp.12272
   PubMed Web of Science ®Google Scholar
• Biederman, J., Mick, E., Fried, R., Wilner, N., Spencer, T. J., & Faraone, S. V. (2011). Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 21(7), 508–515. https://doi.org/10.1016/j.euroneuro.2010.11.005
   PubMed Web of Science ®Google Scholar
• Brown, T. E. (2006). Executive functions and attention deficit hyperactivity disorder: Implications of two conflicting views. International Journal of Disability, Development and Education, 53(1), 35–46. https://doi.org/10.1080/10349120500510024
   Google Scholar
• Brown, T. E., Holdnack, J., Saylor, K., Adler, L., Spencer, T., Williams, D. W., Padival, A. K., Schuh, K., Trzepacz, P. T., & Kelsey, D. (2011). Effect of atomoxetine on executive function impairments in adults with ADHD. Journal of Attention Disorders, 15(2), 130–138. https://doi.org/10.1177/1087054709356165
   PubMed Web of Science ®Google Scholar
• Çetin, F. H., Torun, Y. T., & Taner, Y. I. (2015). Dikkat Eksikligi Hiperaktivite Bozuklugu Tedavisinde Atomoksetin ve Osmotik Salinimli Metilfenidat: Etkinlik ve Yan Etki Profilinin Degerlendirildigi Alti Aylik Izlem Çlismasi [Atomoxetine Versus Oros Methylphenidate in Attention Deficit Hyperactivity Disorder: A Six-Month Follow Up Study for Efficacy and Adverse Effects]. Türkiye Klinikleri. Tip Bilimleri Dergisi, 35(2), 88.
   Google Scholar
• Coghill, D., Seth, S., Pedroso, S., Usala, T., Currie, J., & Gagliano, A. (2014). Effects of methylphenidate on cognitive functions in children and adolescents with ADHD: Evidence from a systematic review and a meta-analysis. Biological Psychiatry, 76(8), 603–615. https://doi.org/10.1016/j.biopsych.2013.10.005
   PubMed Web of Science ®Google Scholar
• Conners, C. K. (1969). A teacher rating scale for use in drug studies with children. The American Journal of Psychiatry, 126(6), 884–888. https://doi.org/10.1176/ajp.126.6.884
   PubMed Web of Science ®Google Scholar
• Dereboy, C., Senol, S., Sener, S., & Dereboy, F. (2007). Validation of the Turkish versions of the short-form Conners' teacher and parent rating scales. Turk psikiyatri dergisi [Turkish Journal of Psychiatry], 18(1), 48–58.
   PubMed Web of Science ®Google Scholar
• Fallu, A., Richard, C., Prinzo, R., & Binder, C. (2006). Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder. Current Medical Research and Opinion, 22(12), 2557–2566. https://doi.org/10.1185/030079906X154132
   PubMed Web of Science ®Google Scholar
• Faraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., & Seidman, L. (2005). Atomoxetine and Stroop task performance in adult attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 15(4), 664–670. https://doi.org/10.1089/cap.2005.15.664
   PubMed Web of Science ®Google Scholar
• Gao, H., Zhao, Y., Levine, L., & Allen, A. (2006). Determining cut-points for clinically meaningful improvement: A receiver operating characteristic approach. In Scientific Proceedings of the 53rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry. American Academy of Child and Adolescent Psychiatry.
   Google Scholar
• Gau, S. S. F., & Shang, C. Y. (2010). Improvement of executive functions in boys with attention deficit hyperactivity disorder: An open-label follow-up study with once-daily atomoxetine. The International Journal of Neuropsychopharmacology, 13(2), 243–256. https://doi.org/10.1017/S1461145709990836
   PubMed Web of Science ®Google Scholar
• Gioia, G. A., Isquith, P. K., & Guy, S. C. (2000). Construct validity of the behavior rating inventory of executive function (BRIEF). Journal of the International Neuropsychological Society, 6, 139.
   Google Scholar
• Gioia, G. A., Isquith, P. K., Retzlaff, P. D., & Espy, K. A. (2002). Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a clinical sample. Child Neuropsychology, 8(4), 249–257. https://doi.org/10.1076/chin.8.4.249.13513
   PubMed Web of Science ®Google Scholar
• Gökler, B., Ünal, F., Pehlivantürk, B., Kültür, E. Ç., Akdemir, D., & Taner, Y. (2004). Reliability and validity of schedule for affective disorders and Schizophrenia for school age children-present and lifetime version-Turkish version (K-SADS-PL-T)[in Turkish]. Turk Journal of Child Adolescence Mental Health, 11, 109–116.
   Google Scholar
• Goyette, C. H., Conners, C. K., & Ulrich, R. F. (1978). Normative data on revised Conners parent and teacher rating scales. Journal of Abnormal Child Psychology, 6(2), 221–236. https://doi.org/10.1007/BF00919127
   PubMed Web of Science ®Google Scholar
• Grane, V. A., Endestad, T., Pinto, A. F., & Solbakk, A. K. (2014). Attentional control and subjective executive function in treatment-naive adults with attention deficit hyperactivity disorder. PLOS One, 9(12), e115227. https://doi.org/10.1371/journal.pone.0115227
   PubMed Web of Science ®Google Scholar
• Homack, S., & Riccio, C. A. (2004). A meta-analysis of the sensitivity and specificity of the Stroop Color and Word Test with children. Archives of Clinical Neuropsychology, 19(6), 725–743. https://doi.org/10.1016/j.acn.2003.09.003
   PubMed Web of Science ®Google Scholar
• Isquith, P. K., & Gioia, G. A. (2000). BRIEF predictions of ADHD: clinical utility of the Behavior Rating Inventory of Executive Function for detecting ADHD subtypes in children. Archives of Clinical Neuropsychology, 15(8), 780–781. https://doi.org/10.1093/arclin/15.8.780a
   Web of Science ®Google Scholar
• Kaplan, B. J., Dewey, D., Crawford, S. G., & Fisher, G. C. (1998). Deficits in long-term memory are not characteristic of ADHD. Journal of Clinical and Experimental Neuropsychology, 20(4), 518–528. https://doi.org/10.1076/jcen.20.4.518.1477
   PubMed Web of Science ®Google Scholar
• Karakas, S. (2004). Handbook of BILNOT Battery: Studies of research and development for neuropsychological tests. Dizayn Ofset.
   Google Scholar
• Karakaya, I., Yıldız, Ö. & Şişmanlar, Ş. (2006). Metilfenidatın Dikkat Eksikliği Hiperaktivite Bozukluğu olan çocuklarda dikkat ve yürütücü işlevler üzerine etkisi: Bir olgu serisi. Çocuk ve Gençlik Ruh Sağlığı Dergisi, 13(69), 75.
   Google Scholar
• Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., Williamson, D., & Ryan, N. (1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry, 36(7), 980–988. https://doi.org/10.1097/00004583-199707000-00021
   PubMed Web of Science ®Google Scholar
• Kılıç, B. G., Irak, M., Koçkar, A. İ., Şener, Ş., & Karakaş, S. (2002). İşaretleme Testi Türk Formu'nun 6-11 Yaş Grubu Çocuklarda Standardizasyon Çalışması. Klinik Psikiyatri Dergisi, 5(4), 213–228.
   Google Scholar
• Kılıç, B., Koçkar, A., Irak, M., Şener, Ş., & Karakaş, S. (2002). The standardization study of the Stroop test TBAG form in children between 6 and 11 years of age. Turkish Journal of Child Adolescent Mental Health, 9(2), 86–99.
   Google Scholar
• Kiliç, B. G., Sener, S., Koçkar, A. I., & Karakaş, S. (2007). Multicomponent attention deficits in attention deficit hyperactivity disorder. Psychiatry and Clinical Neurosciences, 61(2), 142–148. https://doi.org/10.1111/j.1440-1819.2007.01629.x
   PubMed Web of Science ®Google Scholar
• Kiriş, N., Tahiroğlu, A. Y., Avci, A., Hergüner, Ö., Altunbaşak, Ş., & Karakaş, S. (2013). Dikkat Eksikliği Hiperaktivite Bozukluğu Olan Çocuklarda Metilfenidatın Nöropsikolojik İşlevler Üzerine Etkisi. Turkiye Klinikleri Journal of Medical Sciences, 33(3), 797–805. https://doi.org/10.5336/medsci.2012-31505
   Google Scholar
• Konrad, K., Günther, T., Heinzel-Gutenbrunner, M., & Herpertz-Dahlmann, B. (2005). Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial. Journal of Child and Adolescent Psychopharmacology, 15(2), 180–190. https://doi.org/10.1089/cap.2005.15.180
   PubMed Web of Science ®Google Scholar
• Kratochvil, C. J., Heiligenstein, J. H., Dittmann, R., Spencer, T. J., Biederman, J., Wernicke, J., Newcorn, J. H., Casat, C., Milton, D., & Michelson, D. (2002). Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41(7), 776–784. https://doi.org/10.1097/00004583-200207000-00008
   PubMed Web of Science ®Google Scholar
• Landau, Y. E., Gross-Tsur, V., Auerbach, J. G., Van der Meere, J., & Shalev, R. S. (1999). Attention-deficit hyperactivity disorder and developmental right-hemisphere syndrome: Congruence and incongruence of cognitive and behavioral aspects of attention. Journal of Child Neurology, 14(5), 299–303. https://doi.org/10.1177/088307389901400506
   PubMed Web of Science ®Google Scholar
• MacLeod, C. M. (1992). The Stroop task: The “gold standard” of attentional measures. Journal of Experimental Psychology: General, 121(1), 12–14. https://doi.org/10.1037/0096-3445.121.1.12
   Web of Science ®Google Scholar
• Maziade, M., Rouleau, N., Lee, B., Rogers, A., Davis, L., & Dickson, R. (2009). Atomoxetine and neuropsychological function in children with attention-deficit/hyperactivity disorder: Results of a pilot study. Journal of Child and Adolescent Psychopharmacology, 19(6), 709–718. https://doi.org/10.1089/cap.2008.0166
   PubMed Web of Science ®Google Scholar
• Newcorn, J. H., Kratochvil, C. J., Allen, A. J., Casat, C. D., Ruff, D. D., Moore, R. J., & Michelson, D., Atomoxetine/Methylphenidate Comparative Study Group (2008). Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: Acute comparison and differential response. The American Journal of Psychiatry, 165(6), 721–730. https://doi.org/10.1176/appi.ajp.2007.05091676
   PubMed Web of Science ®Google Scholar
• Ni, H. C., Shang, C. Y., Gau, S. S. F., Lin, Y. J., Huang, H. C., & Yang, L. K. (2013). A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder. The International Journal of Neuropsychopharmacology, 16(9), 1959–1973. https://doi.org/10.1017/S1461145713000357
   PubMed Web of Science ®Google Scholar
• O’Driscoll, G. A., Dépatie, L., Holahan, A. L. V., Savion-Lemieux, T., Barr, R. G., Jolicoeur, C., & Douglas, V. I. (2005). Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder. Biological Psychiatry, 57(11), 1452–1460. https://doi.org/10.1016/j.biopsych.2005.02.029
   PubMed Web of Science ®Google Scholar
• Prasad, S., Harpin, V., Poole, L., Zeitlin, H., Jamdar, S., Puvanendran, K., & Group, S. S., on behalf of the SUNBEAM Study Group (2007). A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Current Medical Research and Opinion, 23(2), 379–394. https://doi.org/10.1185/030079906X167309
   PubMed Web of Science ®Google Scholar
• Shang, C. Y., & Gau, S. S. F. (2012). Improving visual memory, attention, and school function with atomoxetine in boys with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 22(5), 353–363. https://doi.org/10.1089/cap.2011.0149
   PubMed Web of Science ®Google Scholar
• Soysal, S. (2007). Dikkat eksikliği hiperaktivite bozukluğu alttiplerinde dikkat yönetici işlevler ve üst-biliş performansının oluşturduğu ilişkiler örüntüsünün incelenmesi [Doktora Tezi [Doctoral dissertation]]. Hacettepe Üniversitesi, Sosyal Bilimler Enstitüsü, Ankara, 2007 (Thesis in Turkish).
   Google Scholar
• Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18(6), 643–662. https://doi.org/10.1037/h0054651
   Google Scholar
• Su, Y., Yang, L., Stein, M. A., Cao, Q., & Wang, Y. (2016). Osmotic release oral system methylphenidate versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in Chinese youth: 8-week comparative efficacy and 1-year follow-up. Journal of Child and Adolescent Psychopharmacology, 26(4), 362–371. https://doi.org/10.1089/cap.2015.0031
   PubMed Web of Science ®Google Scholar
• Tasdelen, B. I., Karakaya, E., & Oztop, D. B. (2015). Effects of atomoxetine and osmotic release oral system-methylphenidate on executive functions in patients with combined type attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 25(6), 494–500. https://doi.org/10.1089/cap.2014.0155
   PubMed Web of Science ®Google Scholar
• Wehmeier, P. M., Schacht, A., Wolff, C., Otto, W. R., Dittmann, R. W., & Banaschewski, T. (2011). Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: Results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device. Journal of Child and Adolescent Psychopharmacology, 21(5), 433–444. https://doi.org/10.1089/cap.2010.0142
   PubMed Web of Science ®Google Scholar
• Weintraub, S., & Mesulam, M. M. (1985). Verbal and Nonverbal Cancellation Test. FA Davis.
   Google Scholar
• Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005). Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biological Psychiatry, 57(11), 1336–1346. https://doi.org/10.1016/j.biopsych.2005.02.006
   PubMed Web of Science ®Google Scholar
• Yang, L., Cao, Q., Shuai, L., Li, H., Chan, R. C., & Wang, Y. (2012). Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: A randomized controlled trial. The International Journal of Neuropsychopharmacology, 15(1), 15–26. https://doi.org/10.1017/S1461145711001490
   PubMed Web of Science ®Google Scholar
• Yildiz, O., Sismanlar, S. G., Memik, N. C., Karakaya, I., & Agaoglu, B. (2011). Atomoxetine and methylphenidate treatment in children with ADHD: The efficacy, tolerability and effects on executive functions. Child Psychiatry and Human Development, 42(3), 257–269. https://doi.org/10.1007/s10578-010-0212-3
   PubMed Web of Science ®Google Scholar
• Yilmaz, A., Gokcen, C., Fettahoglu, E. C., & Ozatalay, E. (2013). The effect of methylphenidate on executive functions in children with attention-deficit hyperactivity disorder. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 23(2), 162–170. https://doi.org/10.5455/bcp.20121130090251
   Web of Science ®Google Scholar
• Zheng, Y., Liang, J. M., Gao, H. Y., Yang, Z. W., Jia, F. J., Liang, Y. Z., & Zhuo, J. M. (2015). An open-label, self-control, prospective study on cognitive function, academic performance, and tolerability of osmotic-release oral system methylphenidate in children with attention-deficit hyperactivity disorder. Chinese Medical Journal, 128(22), 2988.
   PubMed Web of Science ®Google Scholar